MBC BioLabs: NCI SBIR Lunch Seminar and One-on-One Meetings

Dear MBC BioLabs Community,

You are invited to Meet with NCI SBIR!

Date: Monday, September 10, 2018

Agenda:

11:30-12:00pm : Networking and Lunch Served

12:00-1:00pm : Lunch Seminar and Q&A

1:30-4:00pm : One-on-One Meetings with NCI SBIR

Place: 953 Indiana Street, San Francisco

Lunch at Community Room and Meetings at 2nd Floor Conference Rooms

Please contact kory.hallett@nih.gov for One-on-One Meeting (deadline: September 4th)

About the Event:

Are you a small business in the Bay Area looking for funding to advance your cancer research? If so, then join NCI SBIR Program Directors Drs. Kory Hallett and Ming Zhao at QB3, San Francisco on Monday, September 10th to learn about new and existing funding opportunities, NCI SBIR programs and resources. You are also welcome to have one-on-one meetings with the program directors. If you would like to sign up for a meeting with either Dr. Hallett or Dr. Zhao, please send your name, company name and a brief executive summary of your technology to kory.hallett@nih.gov by September 4th, 2018.

If you are planning to submit an SBIR application to the January 5th receipt date, this event will give you an opportunity to discuss your specific aims with Drs. Hallett or Zhao. In order to take advantage of the program directors at your location, please send a one-page draft of your specific aims in place of an executive summary for a one-on-one discussion.

Speakers:

Kory Hallett

Kory Hallett is a Program Director in the Small Business Innovation Research Development Center at the National Cancer Institute. Kory manages program evaluation for the Development Center, and serves as a program officer to SBIR and STTR grants in the areas of immunology, immunotherapy, and monoclonal antibody technology. She also participates in the Center's many initiatives to support the development of innovative cancer technologies. Kory initially joined the NCI SBIR Development Center in 2014 as a Science & Technology Policy Fellow with the American Association for the Advancement of Science (AAAS).

Kory received her doctorate in Cell and Molecular Biology in 2009 from the University of Nevada, Reno. She completed a postdoctoral research fellowship at the University of Wisconsin-Madison, where she worked in a translational lab researching monoclonal antibody-based therapeutics for pediatric neuroblastoma.

Ming Zhao

Ming Zhao, Ph.D., is a Program Director in the SBIR Development Center at the National Cancer Institute. In this role, Dr. Zhao develops and manages SBIR/STTR programs and contracts focused on cancer therapeutics, molecular diagnostics and medical imaging. Prior to his appointment at NCI in 2009, he worked in industry including GE and Pfizer for over ten years.